Clinical Trial Update: Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating ZG005 in combination with etoposide and cisplatin for advanced neuroendocrine carcinoma. The study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• ZG005

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Neuroendocrine Carcinoma | Phase 1, Phase 2 | Status: RECRUITING